Evidence map›Paper›PMID 42497960›Full record

ArticleExperimental hematology2026

Loss of Function Dnmt3a Mutation Leads to Aberrant Neutrophil Migration.

Frieda Zimmer, Daniel E Kennedy, Spencer L Redding, Ruoqiong Cao, Sarah M Waldvogel, Apoorva Thatavarty, Bryan Bahoua, Brandon T Tran, Arushana A Maknojia, Margaret A Goodell and 3 more

Abstract read
In one paragraph

Article in Experimental hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Frieda ZimmerDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Daniel E KennedyDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Spencer L ReddingDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Ruoqiong CaoDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX.
Sarah M WaldvogelGraduate Program in Cancer and Cell Biology, Baylor College of Medicine, Houston, TX; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX; Department of Molecular and Cellular Biology, Stem Cells and Regenerative Medicine Center, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
Apoorva ThatavartyDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX; Graduate Program in Genetics and Genomics, Baylor College of Medicine, Houston, TX.
Bryan BahouaDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX; Graduate Program in Cancer and Cell Biology, Baylor College of Medicine, Houston, TX.
Brandon T TranDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX; Graduate Program in Cancer and Cell Biology, Baylor College of Medicine, Houston, TX.
Arushana A MaknojiaDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX; Graduate Program in Immunology and Microbiology, Baylor College of Medicine, Houston, TX.
Margaret A GoodellDepartment of Molecular and Cellular Biology, Stem Cells and Regenerative Medicine Center, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
Antony RodriguezDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, Baylor College of Medicine, Houston, TX.
Katie A MatatallDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Katherine Y KingDepartment of Pediatrics, Division of Infectious Disease, Baylor College of Medicine and Texas Children's Hospital, Houston, TX. Electronic address: kyk@bcm.edu.

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Martha P Mims · 2007 to 2026
$73.9M
Project 3: Contribution of inflammation and DNA damaging factors to clonal expansion and malignant transformation in a community cohort of older adultsP01CA265748 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Koichi Takahashi · 2022 to 2026
$13.6M
Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
REGULATION OF HEMATOPOIETIC PROGENITORS BY DE NOVO DNA METHYLATIONR01DK092883 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2012 to 2024
$7.4M
Training In Cell and Gene TherapyT32HL092332 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MALCOLM K. BRENNER, Bruno Di Stefano · 2008 to 2026
$6.9M
Impact of Infection and Inflammation on Primitive HematopoiesisR35HL155672 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Katherine Yudeh King · 2021 to 2026
$5.1M
The Clinical Translational Research Certificate of Added Qualification ProgramT32GM136554 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Melissa Suter, IGNATIA B VAN DEN VEYVER · 2020 to 2026
$3.0M
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung diseaseR01HL167814 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Antony Rodriguez · 2023 to 2026
$2.1M
The Contribution ofInfection to Preleukemic Clonal HematopoiesisR01HL136333 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI KING, KATHERINE YUDEH · 2017 to 2020
$1.9M
THERMO SCIENTIFIC Q EXACTIVE HF-X HYBRID QUADRUPOLE-ORBITRAP MASS SPECTROMETERS10OD026804 · OD · BAYLOR COLLEGE OF MEDICINE · PI MALOVANNAYA, ANNA · 2019 to 2019
$717k
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
Regulation of Hematopoietic Progenitors by de novo DNA MethylationR56DK092883 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2011 to 2011
$344k
NCI NIH HHS P01 CA265748NCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NHLBI NIH HHS F31 HL164287NHLBI NIH HHS F31 HL168921NHLBI NIH HHS R01 HL136333NHLBI NIH HHS R01 HL167814NHLBI NIH HHS R35 HL155672NHLBI NIH HHS T32 HL092332NICHD NIH HHS F30 HD111129NIDDK NIH HHS R01 DK092883NIDDK NIH HHS R56 DK092883NIDDK NIH HHS T32 DK060445NIGMS NIH HHS T32 GM136554NIH HHS S10 OD026804
6 · The paper itself

Abstract

Clonal hematopoiesis (CH), an age-related expansion of somatically mutated hematopoietic clones, is associated with increased risk of severe infections including coronavirus disease (COVID)-19, yet the underlying mechanisms remain unclear. Here, we investigated the impact of Dnmt3a deficiency in a murine model of influenza A virus (IAV) pneumonia. Dnmt3a-deficient mice exhibited increased pulmonary viral burden and reduced neutrophil accumulation in IAV-infected lungs despite comparable circulating neutrophil numbers. Functional analyses of neutrophils showed impaired chemotactic migration in vitro, whereas maturation, antimicrobial enzyme content, and metabolic capacity were unchanged. Transcriptomic profiling revealed downregulation of pathways involved in chemotaxis, cytokine signaling, and cellular activation, including reduced expression of Cxcr1. Supporting the translational relevance of these findings, proteomic analysis of plasma from individuals with germline DNMT3A mutations (Tatton-Brown-Rahman syndrome) revealed alterations in proteins associated with cell migration and cytoskeletal dynamics. Collectively, our findings demonstrate that Dnmt3a loss compromises innate immune defense by impairing neutrophil migration in a cell-intrinsic manner, leading to ineffective pathogen clearance. This work provides mechanistic insight into how CH-associated mutations contribute to age-associated susceptibility to infection and highlights altered leukocyte trafficking as a potential therapeutic target in aging populations with CH.

Indexed as

Chemotaxis, LeukocyteDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ALoss of Function MutationNeutrophilsOrthomyxoviridae InfectionsAnimalsCOVID-19FemaleHumansMiceMice, KnockoutDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNMT3A protein, humanDnmt3a protein, mouse

Identifiers

PMID42497960
PMCPMC13474270

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.